Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121912664
rs121912664
T 0.710 CausalMutation CLINVAR

dbSNP: rs1555526250
rs1555526250
AGGTCT 0.700 CausalMutation CLINVAR

dbSNP: rs587782620
rs587782620
T 0.700 CausalMutation CLINVAR

dbSNP: rs11540652
rs11540652
T 0.700 GeneticVariation CLINVAR Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer. 9569050

1998

dbSNP: rs28934576
rs28934576
T 0.700 GeneticVariation CLINVAR Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer. 9569050

1998

dbSNP: rs1042522
rs1042522
0.030 GeneticVariation BEFREE Our aim was to evaluate association of R72P with breast cancer risk as well as histopathologic features of the breast tumors and survival. 16033823

2005

dbSNP: rs1131691014
rs1131691014
0.020 GeneticVariation BEFREE Our aim was to evaluate association of R72P with breast cancer risk as well as histopathologic features of the breast tumors and survival. 16033823

2005

dbSNP: rs878854066
rs878854066
0.020 GeneticVariation BEFREE Our aim was to evaluate association of R72P with breast cancer risk as well as histopathologic features of the breast tumors and survival. 16033823

2005

dbSNP: rs11540652
rs11540652
T 0.700 GeneticVariation CLINVAR The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. 16489069

2006

dbSNP: rs121912651
rs121912651
A 0.700 GeneticVariation CLINVAR The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. 16489069

2006

dbSNP: rs28934576
rs28934576
T 0.700 GeneticVariation CLINVAR The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. 16489069

2006

dbSNP: rs1042522
rs1042522
0.030 GeneticVariation BEFREE We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival. 20021639

2009

dbSNP: rs1131691014
rs1131691014
0.020 GeneticVariation BEFREE We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival. 20021639

2009

dbSNP: rs878854066
rs878854066
0.020 GeneticVariation BEFREE We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival. 20021639

2009

dbSNP: rs587781858
rs587781858
0.010 GeneticVariation BEFREE We investigated the effects of the germ-line single nucleotide polymorphisms TP53 R72P (215G>C) and MDM2 SNP309 (-410T>G), and p53 protein expression in breast tumors on survival. 20021639

2009

dbSNP: rs1042522
rs1042522
0.030 GeneticVariation BEFREE Taken together, we showed the preferential loss of the rs1042522 C allele, which is protective against BC progression, in breast tumors. 21810023

2011

dbSNP: rs121912664
rs121912664
0.710 GeneticVariation BEFREE A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil. 23794094

2013

dbSNP: rs17849781
rs17849781
0.710 GeneticVariation BEFREE We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB. 25105660

2014

dbSNP: rs28934874
rs28934874
0.710 GeneticVariation BEFREE We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB. 25105660

2014

dbSNP: rs11540654
rs11540654
0.010 GeneticVariation BEFREE We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB. 25105660

2014

dbSNP: rs876660254
rs876660254
0.010 GeneticVariation BEFREE We have predicted three deleterious coding non-synonymous single nucleotide polymorphisms rs11540654 (R110P), rs17849781 (P278A) and rs28934874 (P151T) in TP53 with a phenotype in breast tumors using computational tools SIFT, Polyphen-2 and MutDB. 25105660

2014

dbSNP: rs17849781
rs17849781
A 0.710 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016

dbSNP: rs17849781
rs17849781
T 0.710 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016

dbSNP: rs28934874
rs28934874
T 0.710 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016

dbSNP: rs28934874
rs28934874
A 0.710 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016